- Home
- ANVS vs VATE Comparison
ANVS vs VATE Comparison
Compare ANVS & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- VATE
- Stock Information
- Founded
- ANVS 2008
- VATE 1994
- Country
- ANVS United States
- VATE United States
- Employees
- ANVS N/A
- VATE 4024
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- VATE Metal Fabrications
- Sector
- ANVS Health Care
- VATE Industrials
- Exchange
- ANVS Nasdaq
- VATE Nasdaq
- Market Cap
- ANVS 110.4M
- VATE 82.6M
- IPO Year
- ANVS 2020
- VATE 1996
- Fundamental
- Price
- ANVS $9.57
- VATE $6.10
- Analyst Decision
- ANVS Strong Buy
- VATE
- Analyst Count
- ANVS 6
- VATE 0
- Target Price
- ANVS $29.67
- VATE N/A
- AVG Volume (30 Days)
- ANVS 341.4K
- VATE 50.3K
- Earning Date
- ANVS 11-06-2024
- VATE 11-06-2024
- Dividend Yield
- ANVS N/A
- VATE N/A
- EPS Growth
- ANVS N/A
- VATE N/A
- EPS
- ANVS N/A
- VATE N/A
- Revenue
- ANVS N/A
- VATE $1,364,600,000.00
- Revenue This Year
- ANVS N/A
- VATE N/A
- Revenue Next Year
- ANVS N/A
- VATE N/A
- P/E Ratio
- ANVS N/A
- VATE N/A
- Revenue Growth
- ANVS N/A
- VATE N/A
- 52 Week Low
- ANVS $4.53
- VATE $3.25
- 52 Week High
- ANVS $22.49
- VATE $14.60
- Technical
- Relative Strength Index (RSI)
- ANVS 58.70
- VATE 71.67
- Support Level
- ANVS $9.00
- VATE $6.18
- Resistance Level
- ANVS $10.54
- VATE $6.49
- Average True Range (ATR)
- ANVS 0.81
- VATE 0.43
- MACD
- ANVS 0.12
- VATE 0.05
- Stochastic Oscillator
- ANVS 74.57
- VATE 86.72
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.